Hailey Bieber’s Rhode went from buzzy launch to billion-dollar buyout in less than three years, landing a landmark ...

Lilly paid $47.5 million upfront to license the non-opioid pain drug candidate CNTX-0290 from Centrexion in 2019. The SSTR4 ...